BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36680759)

  • 1. Incidence of and Risk Factors for Neonatal Hypothyroidism Among Women with Graves' Disease Treated with Antithyroid Drugs Until Delivery.
    Yoshihara A; Noh JY; Inoue K; Watanabe N; Fukushita M; Matsumoto M; Suzuki N; Suzuki A; Kinoshita A; Yoshimura R; Aida A; Imai H; Hiruma S; Sugino K; Ito K
    Thyroid; 2023 Mar; 33(3):373-379. PubMed ID: 36680759
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism.
    Momotani N; Noh JY; Ishikawa N; Ito K
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3633-6. PubMed ID: 9360518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil.
    Momotani N; Yamashita R; Makino F; Noh JY; Ishikawa N; Ito K
    Clin Endocrinol (Oxf); 2000 Aug; 53(2):177-81. PubMed ID: 10931098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy.
    Gianetti E; Russo L; Orlandi F; Chiovato L; Giusti M; Benvenga S; Moleti M; Vermiglio F; Macchia PE; Vitale M; Regalbuto C; Centanni M; Martino E; Vitti P; Tonacchera M
    J Endocrinol Invest; 2015 Sep; 38(9):977-85. PubMed ID: 25840794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperthyroidism in Pregnancy: The Delicate Balance between Too Much or Too Little Antithyroid Drug.
    Gheorghiu ML; Bors RG; Gheorghisan-Galateanu AA; Pop AL; Cretoiu D; Varlas VN
    J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34442037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the timing to reduce the initial dose of antithyroid drugs in patients with Graves' disease.
    Nagayama Y; Eishima K; Hirayu H; Yamashita S; Ashizawa K; Matsuo K; Inoue S; Harakawa S; Morita S; Izumi M
    Endocrinol Jpn; 1990 Dec; 37(6):769-75. PubMed ID: 1714371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-Up of Thyroid Function in Children With Neonatal Hyperthyroidism.
    Pyrżak B; Rumińska M; Witkowska-Sędek E; Kucharska A
    Front Endocrinol (Lausanne); 2022; 13():877119. PubMed ID: 35600602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease.
    Choo YK; Yoo WS; Kim DW; Chung HK
    Thyroid; 2010 Sep; 20(9):949-54. PubMed ID: 20629556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-Dependent Influence of Antithyroid Drugs on the Difference in Free Thyroxine Levels between Mothers with Graves' Hyperthyroidism and Their Neonates.
    Iwaki H; Ohba K; Okada E; Murakoshi T; Kashiwabara Y; Hayashi C; Matsushita A; Sasaki S; Suda T; Oki Y; Gemma R
    Eur Thyroid J; 2021 Jul; 10(5):372-381. PubMed ID: 34540707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.
    Andersen SL; Olsen J; Wu CS; Laurberg P
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4373-81. PubMed ID: 24151287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of single daily dosage of methimazole vs. propylthiouracil in the induction of euthyroidism.
    Homsanit M; Sriussadaporn S; Vannasaeng S; Peerapatdit T; Nitiyanant W; Vichayanrat A
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):385-90. PubMed ID: 11298092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan.
    Yoshihara A; Noh JY; Watanabe N; Mukasa K; Ohye H; Suzuki M; Matsumoto M; Kunii Y; Suzuki N; Kameda T; Iwaku K; Kobayashi S; Sugino K; Ito K
    Thyroid; 2015 Oct; 25(10):1155-61. PubMed ID: 26222916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.
    Yoshihara A; Noh J; Yamaguchi T; Ohye H; Sato S; Sekiya K; Kosuga Y; Suzuki M; Matsumoto M; Kunii Y; Watanabe N; Mukasa K; Ito K; Ito K
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2396-403. PubMed ID: 22547422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of neonates born to women with Graves' disease: a cohort study.
    Besançon A; Beltrand J; Le Gac I; Luton D; Polak M
    Eur J Endocrinol; 2014 Jun; 170(6):855-62. PubMed ID: 24670885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system.
    Lo JC; Rivkees SA; Chandra M; Gonzalez JR; Korelitz JJ; Kuzniewicz MW
    Thyroid; 2015 Jun; 25(6):698-705. PubMed ID: 25747892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graves' disease in pregnancy: TSH receptor binding inhibiting immunoglobulins and maternal and neonatal thyroid function.
    Mortimer RH; Tyack SA; Galligan JP; Perry-Keene DA; Tan YM
    Clin Endocrinol (Oxf); 1990 Feb; 32(2):141-52. PubMed ID: 1971773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graves' disease in two pregnancies complicated by fetal goitrous hypothyroidism: successful in utero treatment with levothyroxine.
    Bliddal S; Rasmussen ÅK; Sundberg K; Brocks V; Skovbo P; Feldt-Rasmussen U
    Thyroid; 2011 Jan; 21(1):75-81. PubMed ID: 21162688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.
    Nakamura H; Noh JY; Itoh K; Fukata S; Miyauchi A; Hamada N
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2157-62. PubMed ID: 17389704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful Re-administration of Low-dose of Methimazole (MMI) in Graves' Disease Patients Who Experienced Allergic Cutaneous Reactions to MMI at Initial Treatment and Had Received Long-term Propylthiouracil (PTU).
    Kubota S
    Intern Med; 2016; 55(22):3235-3237. PubMed ID: 27853063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.